Syndax Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
SNDX Nasdaq 2836 syndax.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Mar 4th, 2026 2:01 pm
Syndax Pharmaceuticals Inc. (SNDX) on a Strong Footing amid Robust Demand for Key Flagship Drugs - Mar 2nd, 2026 12:57 am
Is Syndax (SNDX) Using ESOP Shares and New Drugs to Quietly Redefine Its Investment Story? - Feb 27th, 2026 10:13 pm
Syndax (SNDX) Q4 2025 Earnings Call Transcript - Feb 27th, 2026 10:10 am
Syndax Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Feb 27th, 2026 6:30 am
Syndax Pharmaceuticals Q4 Earnings Call Highlights - Feb 27th, 2026 4:46 am
Syndax Pharmaceuticals Inc (SNDX) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Feb 26th, 2026 10:06 pm
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates - Feb 26th, 2026 4:00 pm
Syndax: Q4 Earnings Snapshot - Feb 26th, 2026 2:47 pm
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Feb 26th, 2026 2:01 pm
Syndax Announces Participation in March Investor Conferences - Feb 23rd, 2026 5:00 am
Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026 - Feb 19th, 2026 5:00 am
Why Analysts See Syndax Pharmaceuticals (SNDX) Story Evolving With New Deals And Refined Valuation - Feb 16th, 2026 3:08 pm
Is Syndax Pharmaceuticals (SNDX) Pricing Reflecting Recent Biotech Reassessment Or Long Term Potential - Feb 15th, 2026 7:08 pm
Syndax Pharmaceuticals Highlights Revuforj, Niktimvo Sales Surge and 2026 Milestones at Guggenheim Conf - Feb 15th, 2026 6:05 am
BofA Raised Syndax (SNDX) PT to $28, Cites Heavy Pre-Announcements Lowering Earnings Impact - Feb 13th, 2026 11:29 pm
Syndax Announces Participation at the 2026 Guggenheim Emerging Outlook: Biotech Summit - Feb 5th, 2026 5:00 am
Syndax Pharmaceuticals, Inc. (SNDX): A Bull Case Theory - Jan 19th, 2026 3:17 pm
Is It Time To Reassess Syndax Pharmaceuticals (SNDX) After Last Year’s 62.5% Share Price Gain? - Jan 14th, 2026 6:08 am
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference - Jan 12th, 2026 5:00 am